These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10730572)

  • 1. New and future drugs in nerve-gut dysfunction.
    Bueno L
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):794-801. PubMed ID: 10730572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-gut interaction in irritable bowel syndrome: new findings of a multicomponent disease model.
    Schmulson MJ
    Isr Med Assoc J; 2001 Feb; 3(2):104-10. PubMed ID: 11347592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensory dysfunction and the irritable bowel syndrome.
    Houghton LA
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):415-27. PubMed ID: 10580918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of inflammatory mediators on gut sensitivity.
    Bueno L; Fioramonti J
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():42A-46A. PubMed ID: 10202208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The gut as a neurological organ.
    Holzer P; Schicho R; Holzer-Petsche U; Lippe IT
    Wien Klin Wochenschr; 2001 Sep; 113(17-18):647-60. PubMed ID: 11603099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irritable bowel syndrome: a model of the brain-gut interactions.
    Mulak A; Bonaz B
    Med Sci Monit; 2004 Apr; 10(4):RA55-62. PubMed ID: 15260348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intestinal sensitivity disorders and irritable bowel syndrome].
    Mei N
    Gastroenterol Clin Biol; 1990; 14(5 ( Pt 2)):29C-32C. PubMed ID: 2210179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to the modulation of abdominal pain.
    Mayer EA; Lembo T; Chang L
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():65A-70A. PubMed ID: 10202211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of the gastrointestinal mucosa by sensory neurons.
    Holzer P; Michl T; Danzer M; Jocic M; Schicho R; Lippe IT
    J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):505-21. PubMed ID: 11787755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptides and inflammatory bowel disease.
    Eysselein VE; Nast CC
    Z Gastroenterol Verh; 1991 Mar; 26():253-7. PubMed ID: 1714164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin and its implication for the management of irritable bowel syndrome.
    Gershon MD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S25-34. PubMed ID: 12776000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-brain neuropeptides in the regulation of ingestive behaviors and obesity.
    Crowell MD; Decker GA; Levy R; Jeffrey R; Talley NJ
    Am J Gastroenterol; 2006 Dec; 101(12):2848-56; quiz 2914. PubMed ID: 17026567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.
    Sanger GJ
    Dig Dis; 1999; 17(2):90-9. PubMed ID: 10545714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-gut connections in functional GI disorders: anatomic and physiologic relationships.
    Jones MP; Dilley JB; Drossman D; Crowell MD
    Neurogastroenterol Motil; 2006 Feb; 18(2):91-103. PubMed ID: 16420287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of sensori-motor functions of the digestive tract in the pathophysiology of irritable bowel syndrome.
    Delvaux M
    Best Pract Res Clin Gastroenterol; 2004 Aug; 18(4):747-71. PubMed ID: 15324712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pathophysiological mechanisms in irritable bowel syndrome.
    Barbara G; De Giorgio R; Stanghellini V; Cremon C; Salvioli B; Corinaldesi R
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():1-9. PubMed ID: 15335408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].
    Obata K; Noguchi K
    Brain Nerve; 2008 May; 60(5):483-92. PubMed ID: 18516970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPV1 receptor signaling mediates afferent nerve sensitization during colitis-induced motility disorders in rats.
    De Schepper HU; De Man JG; Ruyssers NE; Deiteren A; Van Nassauw L; Timmermans JP; Martinet W; Herman AG; Pelckmans PA; De Winter BY
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G245-53. PubMed ID: 17991707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders.
    Blandizzi C
    Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the neuropeptide Y Y1 receptor affects pain sensitivity, neuropeptide transport and expression, and dorsal root ganglion neuron numbers.
    Shi TJ; Li J; Dahlström A; Theodorsson E; Ceccatelli S; Decosterd I; Pedrazzini T; Hökfelt T
    Neuroscience; 2006 Jun; 140(1):293-304. PubMed ID: 16564642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.